Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or Acute Respiratory Infection

NCT05246098 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT05246098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05246098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or Acute Respiratory Infection
Lead sponsor
McMaster University
Phase
Observational
Overall status
Completed
Start date
August 24, 2022
Completion date
October 25, 2025
Enrollment
679 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, respiratory disease, viral infection